BRIEF-Qlaris Bio Announces Positive Topline Data From Two Phase II Trials of QLS-111 in Patients With Primary Open Angle Glaucoma and Ocular Hypertension
Feb 5 (Reuters) -
QLARIS BIO ANNOUNCES POSITIVE TOPLINE DATA FROM TWO PHASE II TRIALS OF QLS-111 IN PATIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION
QLARIS BIO: QLS-111 MET ALL PRIMARY AND SECONDARY ENDPOINTS IN OSPREY AND APTERYX STUDIES
Source text: ID:nBw2Rf8z3a
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.